vs
Side-by-side financial comparison of WM TECHNOLOGY, INC. (MAPS) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $43.1M, roughly 1.6× WM TECHNOLOGY, INC.). WM TECHNOLOGY, INC. runs the higher net margin — -8.3% vs -49.0%, a 40.7% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -9.7%). WM TECHNOLOGY, INC. produced more free cash flow last quarter ($-280.0K vs $-84.7M).
WM Entertainment is a South Korean entertainment company established in 2008 by former singer Lee Won-min. The company is responsible for managing artist Oh My Girl. On April 7, 2021, the company was acquired by RBW.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
MAPS vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.1M | $70.6M |
| Net Profit | $-3.6M | $-34.6M |
| Gross Margin | 94.9% | — |
| Operating Margin | -13.5% | -56.7% |
| Net Margin | -8.3% | -49.0% |
| Revenue YoY | -9.7% | 81958.1% |
| Net Profit YoY | -251.9% | 54.9% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.1M | — | ||
| Q3 25 | $42.2M | $70.6M | ||
| Q2 25 | $44.8M | — | ||
| Q1 25 | $44.6M | — | ||
| Q4 24 | $47.7M | — | ||
| Q3 24 | $46.6M | — | ||
| Q2 24 | $45.9M | — | ||
| Q1 24 | $44.4M | — |
| Q4 25 | $-3.6M | — | ||
| Q3 25 | $2.5M | $-34.6M | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $1.6M | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $3.3M | — | ||
| Q2 24 | $716.0K | — | ||
| Q1 24 | $1.2M | — |
| Q4 25 | 94.9% | — | ||
| Q3 25 | 95.0% | — | ||
| Q2 25 | 94.9% | — | ||
| Q1 25 | 95.0% | — | ||
| Q4 24 | 95.2% | — | ||
| Q3 24 | 95.3% | — | ||
| Q2 24 | 95.1% | — | ||
| Q1 24 | 94.8% | — |
| Q4 25 | -13.5% | — | ||
| Q3 25 | 4.6% | -56.7% | ||
| Q2 25 | 4.4% | — | ||
| Q1 25 | 5.9% | — | ||
| Q4 24 | 9.6% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 8.5% | — |
| Q4 25 | -8.3% | — | ||
| Q3 25 | 5.8% | -49.0% | ||
| Q2 25 | 3.2% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 4.9% | — | ||
| Q3 24 | 7.2% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 2.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $0.02 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $62.4M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $57.2M | $503.0M |
| Total Assets | $190.7M | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $62.4M | — | ||
| Q3 25 | — | $490.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $52.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $57.2M | — | ||
| Q3 25 | $56.9M | $503.0M | ||
| Q2 25 | $52.7M | — | ||
| Q1 25 | $48.5M | — | ||
| Q4 24 | $36.1M | — | ||
| Q3 24 | $29.5M | — | ||
| Q2 24 | $24.5M | — | ||
| Q1 24 | $20.8M | — |
| Q4 25 | $190.7M | — | ||
| Q3 25 | $192.9M | $577.1M | ||
| Q2 25 | $188.1M | — | ||
| Q1 25 | $183.8M | — | ||
| Q4 24 | $181.9M | — | ||
| Q3 24 | $173.6M | — | ||
| Q2 24 | $168.0M | — | ||
| Q1 24 | $165.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0M | $-84.6M |
| Free Cash FlowOCF − Capex | $-280.0K | $-84.7M |
| FCF MarginFCF / Revenue | -0.7% | -120.1% |
| Capex IntensityCapex / Revenue | 7.7% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0M | — | ||
| Q3 25 | $6.4M | $-84.6M | ||
| Q2 25 | $11.1M | — | ||
| Q1 25 | $5.7M | — | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $7.2M | — | ||
| Q2 24 | $12.7M | — | ||
| Q1 24 | $7.4M | — |
| Q4 25 | $-280.0K | — | ||
| Q3 25 | $3.6M | $-84.7M | ||
| Q2 25 | $8.2M | — | ||
| Q1 25 | $2.0M | — | ||
| Q4 24 | $7.3M | — | ||
| Q3 24 | $4.9M | — | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $2.9M | — |
| Q4 25 | -0.7% | — | ||
| Q3 25 | 8.4% | -120.1% | ||
| Q2 25 | 18.3% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 15.2% | — | ||
| Q3 24 | 10.4% | — | ||
| Q2 24 | 21.9% | — | ||
| Q1 24 | 6.4% | — |
| Q4 25 | 7.7% | — | ||
| Q3 25 | 6.8% | 0.2% | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 8.2% | — | ||
| Q4 24 | 4.5% | — | ||
| Q3 24 | 5.1% | — | ||
| Q2 24 | 5.7% | — | ||
| Q1 24 | 10.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.61× | — | ||
| Q2 25 | 7.75× | — | ||
| Q1 25 | 3.44× | — | ||
| Q4 24 | 4.00× | — | ||
| Q3 24 | 2.17× | — | ||
| Q2 24 | 17.67× | — | ||
| Q1 24 | 5.97× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MAPS
| Services | $39.5M | 92% |
| Other | $3.6M | 8% |
VRDN
Segment breakdown not available.
